Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>LONGBIO-B (01779.HK) Starts IPO Today; Entry Fee HKD4,851.44
Recommend 7 Positive 5 Negative 6 |
||||
|
||||
|
Clinical-stage biopharmaceutical company LONGBIO-B (01779.HK) announced details of its global offering, planning to issue 14.1932 million H shares, of which 10% will be offered in the Hong Kong public offering and 90% in the international offering. The offer price is HKD96.06 per share. Each board lot comprises 50 shares, with an entry fee of HKD4,851.44 per board lot. The IPO starts today (May 28) and will close at noon next Tuesday (June 2). Listing is expected next Friday (June 5). The sole sponsor is Sinolink Securities (Hong Kong). The company introduced nine cornerstone investors for the listing, including OrbiMed Funds, TruMed Funds, GBAHIL, and FR M, which collectively subscribed for USD87 million worth of shares. The company expected to raise net proceeds of approximately HKD1.255 billion from the listing. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
